| Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial HD Bear, G Tang, P Rastogi, CE Geyer, Q Liu, A Robidoux, L Baez-Diaz, ... The lancet oncology 16 (9), 1037-1048, 2015 | 164 | 2015 |
| 21-gene recurrence score and locoregional recurrence in node-positive/ER-positive breast cancer treated with chemo-endocrine therapy EP Mamounas, Q Liu, S Paik, FL Baehner, G Tang, JH Jeong, SR Kim, ... JNCI: Journal of the National Cancer Institute 109 (4), djw259, 2017 | 128 | 2017 |
| Cigarette smoking, physical activity, and alcohol consumption as predictors of cancer incidence among women at high risk of breast cancer in the NSABP P-1 trial SR Land, Q Liu, DL Wickerham, JP Costantino, PA Ganz Cancer epidemiology, biomarkers & prevention 23 (5), 823-832, 2014 | 58 | 2014 |
| Symptoms and QOL as predictors of chemoprevention adherence in NRG Oncology/NSABP Trial P-1 SR Land, FL Walcott, Q Liu, DL Wickerham, JP Costantino, PA Ganz Journal of the National Cancer Institute 108 (4), djv365, 2016 | 43 | 2016 |
| 21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology EP Mamounas, G Tang, S Paik, FL Baehner, Q Liu, JH Jeong, SR Kim, ... Breast cancer research and treatment 168, 69-77, 2018 | 42 | 2018 |
| The importance of systemic therapy in minimizing local recurrence after breast‐conserving surgery: The NSABP experience EP Mamounas, G Tang, Q Liu Journal of surgical oncology 110 (1), 45-50, 2014 | 42 | 2014 |
| The first study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed or refractory low-grade gliomas DH M.W. Kieran, E. Bouffet, U. Tabori, A. Broniscer, K. Cohen, J. Hansford ... Annals of Oncology 27 (6), 2016 | 37* | 2016 |
| Abstract S1-10: Association between the 21-gene recurrence score (RS) and benefit from adjuvant paclitaxel (Pac) in node-positive (N+), ER-positive breast cancer patients (pts … EP Mamounas, G Tang, S Paik, FL Baehner, Q Liu, JH Jeong, SR Kim, ... Cancer Research 72 (24_Supplement), S1-10-S1-10, 2012 | 29* | 2012 |
| Prognostic impact of the 21-gene recurrence score (RS) on disease-free and overall survival of node-positive, ER-positive breast cancer patients (pts) treated with adjuvant … EP Mamounas, G Tang, S Paik, FL Baehner, Q Liu, JH Jeong, SR Kim, ... Journal of Clinical Oncology 30 (27_suppl), 1-1, 2012 | 25 | 2012 |
| The 21-gene recurrence score (RS) predicts risk of loco-regional recurrence (LRR) in node (+), ER (+) breast cancer (BC) after adjuvant chemotherapy and tamoxifen: results from … EP Mamounas, G Tang, S Paik, FL Baehner, Q Liu, J Jeong, S Kim, ... ANNALS OF SURGICAL ONCOLOGY 20, S6-S6, 2013 | 14 | 2013 |
| Prospective assessment of a nasopharyngeal carcinoma risk score in a population undergoing screening GH Chen, Z Liu, MF Ji, RM Pfeiffer, QH Huang, YQ Lu, SH Xie, CY Lin, ... International Journal of Cancer 148 (10), 2398-2406, 2021 | 13 | 2021 |
| Abstract PD2-1: The effect on overall and disease-free survival (OS & DFS) by adding bevacizumab and/or antimetabolites to standard neoadjuvant chemotherapy: NSABP Protocol B-40 HD Bear, G Tang, P Rastogi, CE Geyer, Q Liu, A Robidoux, JN Atkins, ... Cancer Research 75 (9_Supplement), PD2-1-PD2-1, 2015 | 9 | 2015 |
| Robust prediction of the cumulative incidence function under non‐proportional subdistribution hazards Q Liu, G Tang, JP Costantino, CCH Chang Canadian Journal of Statistics 44 (2), 127-141, 2016 | 6 | 2016 |
| Landmark proportional subdistribution hazards models for dynamic prediction of cumulative incidence functions Q Liu, G Tang, JP Costantino, CCH Chang Journal of the Royal Statistical Society Series C: Applied Statistics 69 (5 …, 2020 | 5 | 2020 |
| Dynamic prediction models for data with competing risks Q Liu University of Pittsburgh, 2015 | 2 | 2015 |
| Patient-reported outcomes and behavioral risk factors as predictors of chemoprevention adherence among women in the National Surgical Adjuvant Breast and Bowel Program (NSABP … SR Land, FL Walcott, Q Liu, DL Wickerham, JP Costantino, PA Ganz Journal of Clinical Oncology 32 (15_suppl), 1512-1512, 2014 | 2 | 2014 |
| Effect of adjuvant systemic therapy in reducing rates of loco-regional recurrence in early-stage breast cancer: Results from nine NSABP randomized phase III trials EP Mamounas, G Tang, Q Liu, JH Jeong, TB Julian, P Rastogi, CE Geyer, ... CANCER RESEARCH 75 (9), 2015 | 1 | 2015 |
| A Bayesian single-arm study design accounting for uncertain historical control rates S Wandel, Q Liu, S Green, B Neuenschwander PSI Conference, 2017 | | 2017 |
| Abstract P5-21-01: Effect of adjuvant systemic therapy in reducing rates of loco-regional recurrence in early-stage breast cancer: Results from nine NSABP randomized phase III … EP Mamounas, G Tang, Q Liu, JH Jeong, TB Julian, P Rastogi, CE Geyer, ... Cancer Research 75 (9_Supplement), P5-21-01-P5-21-01, 2015 | | 2015 |
| Patient-reported outcomes and behavioral risk factors as predictors of chemoprevention adherence among women in the National Surgical Adjuvant Breast and Bowel Program (NSABP … SRL FL Walcott, Q Liu, DL. Wickerham, JP. Costantino, PA. Ganz ASCO Annual Meeting 32 (15), 2014 | | 2014 |
